BVXV Annual ROE
329.32%
+1164.96%+139.41%
31 December 2022
Summary:
As of January 21, 2025, BVXV annual return on equity is 329.32%, with the most recent change of +1164.96% (+139.41%) on December 31, 2022. During the last 3 years, it has risen by +161.47% (+96.20%).BVXV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly ROE
246.93%
-663.18%-72.87%
30 June 2023
Summary:
As of January 21, 2025, BVXV quarterly return on equity is 246.93%, with the most recent change of -663.18% (-72.87%) on June 30, 2023. Over the past year, it has increased by +588.93% (+172.20%).BVXV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +139.4% | +172.2% |
| 3 y3 years | +96.2% | +17.9% |
| 5 y5 years | +636.2% | +325.4% |
BVXV ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -73.7% |
BiondVax Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | 246.93%(-72.9%) |
| Mar 2023 | - | 910.11%(-428.8%) |
| Dec 2022 | 329.32%(-139.4%) | -276.76%(+95.2%) |
| Sept 2022 | - | -141.79%(-58.5%) |
| June 2022 | - | -342.00%(+14.7%) |
| Mar 2022 | - | -298.21%(+10.9%) |
| Dec 2021 | -835.64%(-2838.0%) | -268.94%(-66.8%) |
| Sept 2021 | - | -809.21%(-264.5%) |
| June 2021 | - | 491.96%(+646.4%) |
| Mar 2021 | - | 65.91%(+389.7%) |
| Dec 2020 | 30.52%(-81.8%) | 13.46%(-81.1%) |
| Sept 2020 | - | 71.30%(-66.0%) |
| June 2020 | - | 209.45%(+0.4%) |
| Mar 2020 | - | 208.57%(-10.8%) |
| Dec 2019 | 167.85%(-40.3%) | 233.79%(-17.4%) |
| Sept 2019 | - | 283.08%(-8.1%) |
| June 2019 | - | 308.06%(-67.2%) |
| Mar 2019 | - | 940.03%(-223.9%) |
| Dec 2018 | 281.04% | -758.72%(+356.2%) |
| Sept 2018 | - | -166.31%(+51.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | -109.54%(+37.6%) |
| Mar 2018 | - | -79.58%(+0.1%) |
| Dec 2017 | -61.42%(+71.3%) | -79.53%(+17.1%) |
| Sept 2017 | - | -67.93%(-38.8%) |
| June 2017 | - | -111.08%(+61.1%) |
| Mar 2017 | - | -68.96%(+121.1%) |
| Dec 2016 | -35.85%(+17.9%) | -31.19%(-4.1%) |
| Sept 2016 | - | -32.52%(+41.5%) |
| June 2016 | - | -22.98%(-22.5%) |
| Mar 2016 | - | -29.64%(-13.4%) |
| Dec 2015 | -30.40%(-35.1%) | -34.24%(+5.0%) |
| Sept 2015 | - | -32.61%(-32.3%) |
| June 2015 | - | -48.20%(+5.2%) |
| Mar 2015 | - | -45.83%(+2.3%) |
| Dec 2014 | -46.81%(+39.7%) | -44.79%(+12.5%) |
| Sept 2014 | - | -39.83%(+13.4%) |
| June 2014 | - | -35.13%(+36.5%) |
| Mar 2014 | - | -25.73%(+46.4%) |
| Dec 2013 | -33.50%(-20.3%) | -17.57% |
| Dec 2012 | -42.02% | - |
FAQ
- What is BiondVax Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual ROE year-on-year change?
- What is BiondVax Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly ROE year-on-year change?
What is BiondVax Pharmaceuticals annual return on equity?
The current annual ROE of BVXV is 329.32%
What is the all time high annual ROE for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual return on equity is 329.32%
What is BiondVax Pharmaceuticals annual ROE year-on-year change?
Over the past year, BVXV annual return on equity has changed by +1164.96% (+139.41%)
What is BiondVax Pharmaceuticals quarterly return on equity?
The current quarterly ROE of BVXV is 246.93%
What is the all time high quarterly ROE for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly return on equity is 940.03%
What is BiondVax Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, BVXV quarterly return on equity has changed by +588.93% (+172.20%)